The average one-year price target for MicroVision (NasdaqGM:MVIS) has been revised to $3.06 / share. This is an increase of 20.00% from the prior estimate of $2.55 dated February 1, 2026. The price ...
Fintel reports that on November 12, 2025, D. Boral Capital maintained coverage of MicroVision (NasdaqGM:MVIS) with a Buy recommendation. As of November 8, 2025, the average one-year price target for ...
Fulcrum shares plunged to a 52-week low of about $2.90 after the company halted development of its lead sickle cell disease drug, pociredir. ・Heron shares fell to a record low of $0.44 after a federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results